Industry Research Reports
Home > Reports > Service & Software > Global Carrier Screening Tests Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Carrier Screening Tests Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Service & Software
Published Date: 2025-08-05
Pages: 188 Pages
Report ld: 4887548
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Carrier Screening Tests market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Carrier screening tests are genetic tests used to determine if an individual carries one or more mutations in their genes that could be passed on to their offspring. These mutations can cause genetic disorders, even if the carrier does not exhibit symptoms themselves.
Carrier screening can provide valuable information, helping individuals and couples make informed decisions about their reproductive options.
From a downstream perspective, Couple accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Carrier Screening Tests leading manufacturers including Thermo Fisher Scientific, Eurofins Scientific, Illumina, Invitae, MedGenome, Myriad Genetics, Roche, Natera, OPKO Health, 23andMe, etc., dominate supply; the top five capture approximately % of global revenue, with Thermo Fisher Scientific leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Carrier Screening Tests market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Thermo Fisher Scientific
- Eurofins Scientific
- Illumina
- Invitae
- MedGenome
- Myriad Genetics
- Roche
- Natera
- OPKO Health
- 23andMe
- bioMérieux
- EKF Diagnostics
- Gene by Gene (myDNA)
- Fulgent Genetics
- NxGen MDx
- Sonic Genetics
- My Baby
- AncestryDNA
- DiaSorin
- Grifols
- BGI Genomics
- Chigene
- Jiajian Medical Testing
- Genesky
- Berry Genomics
- Weihansi Biomedical Technology
- Annaroad
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- NGS
- Whole Exome Sequencing
- Others
Segment by Application
- Couple
- Individual
CHAPTER OUTLINE
Chapter 1: Defines the Carrier Screening Tests study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Carrier Screening Tests: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Carrier Screening Tests Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 NGS
1.2.3 Whole Exome Sequencing
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global Carrier Screening Tests Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Couple
1.3.3 Individual
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Carrier Screening Tests Revenue Estimates and Forecasts 2020-2031
2.2 Global Carrier Screening Tests Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Carrier Screening Tests Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Carrier Screening Tests Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 NGS Market Size by Players
3.3.2 Whole Exome Sequencing Market Size by Players
3.3.3 Others Market Size by Players
3.4 Global Carrier Screening Tests Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Carrier Screening Tests Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Carrier Screening Tests Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Carrier Screening Tests Market Size by Type (2020-2031)
6.4 North America Carrier Screening Tests Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Carrier Screening Tests Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Carrier Screening Tests Market Size by Type (2020-2031)
7.4 Europe Carrier Screening Tests Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Carrier Screening Tests Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Carrier Screening Tests Market Size by Type (2020-2031)
8.4 Asia-Pacific Carrier Screening Tests Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Carrier Screening Tests Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Carrier Screening Tests Market Size by Type (2020-2031)
9.4 Central and South America Carrier Screening Tests Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Carrier Screening Tests Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Carrier Screening Tests Market Size by Type (2020-2031)
10.4 Middle East and Africa Carrier Screening Tests Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Carrier Screening Tests Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Corporation Information
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Carrier Screening Tests Product Features and Attributes
11.1.4 Thermo Fisher Scientific Carrier Screening Tests Revenue and Gross Margin (2020-2025)
11.1.5 Thermo Fisher Scientific Carrier Screening Tests Revenue by Product in 2024
11.1.6 Thermo Fisher Scientific Carrier Screening Tests Revenue by Application in 2024
11.1.7 Thermo Fisher Scientific Carrier Screening Tests Revenue by Geographic Area in 2024
11.1.8 Thermo Fisher Scientific Carrier Screening Tests SWOT Analysis
11.1.9 Thermo Fisher Scientific Recent Developments
11.2 Eurofins Scientific
11.2.1 Eurofins Scientific Corporation Information
11.2.2 Eurofins Scientific Business Overview
11.2.3 Eurofins Scientific Carrier Screening Tests Product Features and Attributes
11.2.4 Eurofins Scientific Carrier Screening Tests Revenue and Gross Margin (2020-2025)
11.2.5 Eurofins Scientific Carrier Screening Tests Revenue by Product in 2024
11.2.6 Eurofins Scientific Carrier Screening Tests Revenue by Application in 2024
11.2.7 Eurofins Scientific Carrier Screening Tests Revenue by Geographic Area in 2024
11.2.8 Eurofins Scientific Carrier Screening Tests SWOT Analysis
11.2.9 Eurofins Scientific Recent Developments
11.3 Illumina
11.3.1 Illumina Corporation Information
11.3.2 Illumina Business Overview
11.3.3 Illumina Carrier Screening Tests Product Features and Attributes
11.3.4 Illumina Carrier Screening Tests Revenue and Gross Margin (2020-2025)
11.3.5 Illumina Carrier Screening Tests Revenue by Product in 2024
11.3.6 Illumina Carrier Screening Tests Revenue by Application in 2024
11.3.7 Illumina Carrier Screening Tests Revenue by Geographic Area in 2024
11.3.8 Illumina Carrier Screening Tests SWOT Analysis
11.3.9 Illumina Recent Developments
11.4 Invitae
11.4.1 Invitae Corporation Information
11.4.2 Invitae Business Overview
11.4.3 Invitae Carrier Screening Tests Product Features and Attributes
11.4.4 Invitae Carrier Screening Tests Revenue and Gross Margin (2020-2025)
11.4.5 Invitae Carrier Screening Tests Revenue by Product in 2024
11.4.6 Invitae Carrier Screening Tests Revenue by Application in 2024
11.4.7 Invitae Carrier Screening Tests Revenue by Geographic Area in 2024
11.4.8 Invitae Carrier Screening Tests SWOT Analysis
11.4.9 Invitae Recent Developments
11.5 MedGenome
11.5.1 MedGenome Corporation Information
11.5.2 MedGenome Business Overview
11.5.3 MedGenome Carrier Screening Tests Product Features and Attributes
11.5.4 MedGenome Carrier Screening Tests Revenue and Gross Margin (2020-2025)
11.5.5 MedGenome Carrier Screening Tests Revenue by Product in 2024
11.5.6 MedGenome Carrier Screening Tests Revenue by Application in 2024
11.5.7 MedGenome Carrier Screening Tests Revenue by Geographic Area in 2024
11.5.8 MedGenome Carrier Screening Tests SWOT Analysis
11.5.9 MedGenome Recent Developments
11.6 Myriad Genetics
11.6.1 Myriad Genetics Corporation Information
11.6.2 Myriad Genetics Business Overview
11.6.3 Myriad Genetics Carrier Screening Tests Product Features and Attributes
11.6.4 Myriad Genetics Carrier Screening Tests Revenue and Gross Margin (2020-2025)
11.6.5 Myriad Genetics Recent Developments
11.7 Roche
11.7.1 Roche Corporation Information
11.7.2 Roche Business Overview
11.7.3 Roche Carrier Screening Tests Product Features and Attributes
11.7.4 Roche Carrier Screening Tests Revenue and Gross Margin (2020-2025)
11.7.5 Roche Recent Developments
11.8 Natera
11.8.1 Natera Corporation Information
11.8.2 Natera Business Overview
11.8.3 Natera Carrier Screening Tests Product Features and Attributes
11.8.4 Natera Carrier Screening Tests Revenue and Gross Margin (2020-2025)
11.8.5 Natera Recent Developments
11.9 OPKO Health
11.9.1 OPKO Health Corporation Information
11.9.2 OPKO Health Business Overview
11.9.3 OPKO Health Carrier Screening Tests Product Features and Attributes
11.9.4 OPKO Health Carrier Screening Tests Revenue and Gross Margin (2020-2025)
11.9.5 OPKO Health Recent Developments
11.10 23andMe
11.10.1 23andMe Corporation Information
11.10.2 23andMe Business Overview
11.10.3 23andMe Carrier Screening Tests Product Features and Attributes
11.10.4 23andMe Carrier Screening Tests Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 bioMérieux
11.11.1 bioMérieux Corporation Information
11.11.2 bioMérieux Business Overview
11.11.3 bioMérieux Carrier Screening Tests Product Features and Attributes
11.11.4 bioMérieux Carrier Screening Tests Revenue and Gross Margin (2020-2025)
11.11.5 bioMérieux Recent Developments
11.12 EKF Diagnostics
11.12.1 EKF Diagnostics Corporation Information
11.12.2 EKF Diagnostics Business Overview
11.12.3 EKF Diagnostics Carrier Screening Tests Product Features and Attributes
11.12.4 EKF Diagnostics Carrier Screening Tests Revenue and Gross Margin (2020-2025)
11.12.5 EKF Diagnostics Recent Developments
11.13 Gene by Gene (myDNA)
11.13.1 Gene by Gene (myDNA) Corporation Information
11.13.2 Gene by Gene (myDNA) Business Overview
11.13.3 Gene by Gene (myDNA) Carrier Screening Tests Product Features and Attributes
11.13.4 Gene by Gene (myDNA) Carrier Screening Tests Revenue and Gross Margin (2020-2025)
11.13.5 Gene by Gene (myDNA) Recent Developments
11.14 Fulgent Genetics
11.14.1 Fulgent Genetics Corporation Information
11.14.2 Fulgent Genetics Business Overview
11.14.3 Fulgent Genetics Carrier Screening Tests Product Features and Attributes
11.14.4 Fulgent Genetics Carrier Screening Tests Revenue and Gross Margin (2020-2025)
11.14.5 Fulgent Genetics Recent Developments
11.15 NxGen MDx
11.15.1 NxGen MDx Corporation Information
11.15.2 NxGen MDx Business Overview
11.15.3 NxGen MDx Carrier Screening Tests Product Features and Attributes
11.15.4 NxGen MDx Carrier Screening Tests Revenue and Gross Margin (2020-2025)
11.15.5 NxGen MDx Recent Developments
11.16 Sonic Genetics
11.16.1 Sonic Genetics Corporation Information
11.16.2 Sonic Genetics Business Overview
11.16.3 Sonic Genetics Carrier Screening Tests Product Features and Attributes
11.16.4 Sonic Genetics Carrier Screening Tests Revenue and Gross Margin (2020-2025)
11.16.5 Sonic Genetics Recent Developments
11.17 My Baby
11.17.1 My Baby Corporation Information
11.17.2 My Baby Business Overview
11.17.3 My Baby Carrier Screening Tests Product Features and Attributes
11.17.4 My Baby Carrier Screening Tests Revenue and Gross Margin (2020-2025)
11.17.5 My Baby Recent Developments
11.18 AncestryDNA
11.18.1 AncestryDNA Corporation Information
11.18.2 AncestryDNA Business Overview
11.18.3 AncestryDNA Carrier Screening Tests Product Features and Attributes
11.18.4 AncestryDNA Carrier Screening Tests Revenue and Gross Margin (2020-2025)
11.18.5 AncestryDNA Recent Developments
11.19 DiaSorin
11.19.1 DiaSorin Corporation Information
11.19.2 DiaSorin Business Overview
11.19.3 DiaSorin Carrier Screening Tests Product Features and Attributes
11.19.4 DiaSorin Carrier Screening Tests Revenue and Gross Margin (2020-2025)
11.19.5 DiaSorin Recent Developments
11.20 Grifols
11.20.1 Grifols Corporation Information
11.20.2 Grifols Business Overview
11.20.3 Grifols Carrier Screening Tests Product Features and Attributes
11.20.4 Grifols Carrier Screening Tests Revenue and Gross Margin (2020-2025)
11.20.5 Grifols Recent Developments
11.21 BGI Genomics
11.21.1 BGI Genomics Corporation Information
11.21.2 BGI Genomics Business Overview
11.21.3 BGI Genomics Carrier Screening Tests Product Features and Attributes
11.21.4 BGI Genomics Carrier Screening Tests Revenue and Gross Margin (2020-2025)
11.21.5 BGI Genomics Recent Developments
11.22 Chigene
11.22.1 Chigene Corporation Information
11.22.2 Chigene Business Overview
11.22.3 Chigene Carrier Screening Tests Product Features and Attributes
11.22.4 Chigene Carrier Screening Tests Revenue and Gross Margin (2020-2025)
11.22.5 Chigene Recent Developments
11.23 Jiajian Medical Testing
11.23.1 Jiajian Medical Testing Corporation Information
11.23.2 Jiajian Medical Testing Business Overview
11.23.3 Jiajian Medical Testing Carrier Screening Tests Product Features and Attributes
11.23.4 Jiajian Medical Testing Carrier Screening Tests Revenue and Gross Margin (2020-2025)
11.23.5 Jiajian Medical Testing Recent Developments
11.24 Genesky
11.24.1 Genesky Corporation Information
11.24.2 Genesky Business Overview
11.24.3 Genesky Carrier Screening Tests Product Features and Attributes
11.24.4 Genesky Carrier Screening Tests Revenue and Gross Margin (2020-2025)
11.24.5 Genesky Recent Developments
11.25 Berry Genomics
11.25.1 Berry Genomics Corporation Information
11.25.2 Berry Genomics Business Overview
11.25.3 Berry Genomics Carrier Screening Tests Product Features and Attributes
11.25.4 Berry Genomics Carrier Screening Tests Revenue and Gross Margin (2020-2025)
11.25.5 Berry Genomics Recent Developments
11.26 Weihansi Biomedical Technology
11.26.1 Weihansi Biomedical Technology Corporation Information
11.26.2 Weihansi Biomedical Technology Business Overview
11.26.3 Weihansi Biomedical Technology Carrier Screening Tests Product Features and Attributes
11.26.4 Weihansi Biomedical Technology Carrier Screening Tests Revenue and Gross Margin (2020-2025)
11.26.5 Weihansi Biomedical Technology Recent Developments
11.27 Annaroad
11.27.1 Annaroad Corporation Information
11.27.2 Annaroad Business Overview
11.27.3 Annaroad Carrier Screening Tests Product Features and Attributes
11.27.4 Annaroad Carrier Screening Tests Revenue and Gross Margin (2020-2025)
11.27.5 Annaroad Recent Developments
12 Carrier Screening TestsIndustry Chain Analysis
12.1 Carrier Screening Tests Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Carrier Screening Tests Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Carrier Screening Tests Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Carrier Screening Tests Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Carrier Screening Tests Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Carrier Screening Tests Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Carrier Screening Tests Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Carrier Screening Tests Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Carrier Screening Tests Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Carrier Screening Tests Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Carrier Screening Tests by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Carrier Screening Tests as of 2024)
Table 11. Global Carrier Screening Tests Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Carrier Screening Tests Companies Headquarters
Table 13. Global Carrier Screening Tests Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Carrier Screening Tests Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Carrier Screening Tests Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Carrier Screening Tests Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Carrier Screening Tests Revenue by Application (2026-2031) & (US$ Million)
Table 21. Carrier Screening Tests High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Carrier Screening Tests Growth Accelerators and Market Barriers
Table 25. North America Carrier Screening Tests Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Carrier Screening Tests Growth Accelerators and Market Barriers
Table 27. Europe Carrier Screening Tests Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Carrier Screening Tests Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Carrier Screening Tests Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Carrier Screening Tests Investment Opportunities and Key Challenges
Table 31. Central and South America Carrier Screening Tests Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Carrier Screening Tests Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Carrier Screening Tests Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Thermo Fisher Scientific Corporation Information
Table 35. Thermo Fisher Scientific Description and Major Businesses
Table 36. Thermo Fisher Scientific Product Features and Attributes
Table 37. Thermo Fisher Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Thermo Fisher Scientific Revenue Proportion by Product in 2024
Table 39. Thermo Fisher Scientific Revenue Proportion by Application in 2024
Table 40. Thermo Fisher Scientific Revenue Proportion by Geographic Area in 2024
Table 41. Thermo Fisher Scientific Carrier Screening Tests SWOT Analysis
Table 42. Thermo Fisher Scientific Recent Developments
Table 43. Eurofins Scientific Corporation Information
Table 44. Eurofins Scientific Description and Major Businesses
Table 45. Eurofins Scientific Product Features and Attributes
Table 46. Eurofins Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Eurofins Scientific Revenue Proportion by Product in 2024
Table 48. Eurofins Scientific Revenue Proportion by Application in 2024
Table 49. Eurofins Scientific Revenue Proportion by Geographic Area in 2024
Table 50. Eurofins Scientific Carrier Screening Tests SWOT Analysis
Table 51. Eurofins Scientific Recent Developments
Table 52. Illumina Corporation Information
Table 53. Illumina Description and Major Businesses
Table 54. Illumina Product Features and Attributes
Table 55. Illumina Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Illumina Revenue Proportion by Product in 2024
Table 57. Illumina Revenue Proportion by Application in 2024
Table 58. Illumina Revenue Proportion by Geographic Area in 2024
Table 59. Illumina Carrier Screening Tests SWOT Analysis
Table 60. Illumina Recent Developments
Table 61. Invitae Corporation Information
Table 62. Invitae Description and Major Businesses
Table 63. Invitae Product Features and Attributes
Table 64. Invitae Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Invitae Revenue Proportion by Product in 2024
Table 66. Invitae Revenue Proportion by Application in 2024
Table 67. Invitae Revenue Proportion by Geographic Area in 2024
Table 68. Invitae Carrier Screening Tests SWOT Analysis
Table 69. Invitae Recent Developments
Table 70. MedGenome Corporation Information
Table 71. MedGenome Description and Major Businesses
Table 72. MedGenome Product Features and Attributes
Table 73. MedGenome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. MedGenome Revenue Proportion by Product in 2024
Table 75. MedGenome Revenue Proportion by Application in 2024
Table 76. MedGenome Revenue Proportion by Geographic Area in 2024
Table 77. MedGenome Carrier Screening Tests SWOT Analysis
Table 78. MedGenome Recent Developments
Table 79. Myriad Genetics Corporation Information
Table 80. Myriad Genetics Description and Major Businesses
Table 81. Myriad Genetics Product Features and Attributes
Table 82. Myriad Genetics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Myriad Genetics Recent Developments
Table 84. Roche Corporation Information
Table 85. Roche Description and Major Businesses
Table 86. Roche Product Features and Attributes
Table 87. Roche Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Roche Recent Developments
Table 89. Natera Corporation Information
Table 90. Natera Description and Major Businesses
Table 91. Natera Product Features and Attributes
Table 92. Natera Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Natera Recent Developments
Table 94. OPKO Health Corporation Information
Table 95. OPKO Health Description and Major Businesses
Table 96. OPKO Health Product Features and Attributes
Table 97. OPKO Health Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. OPKO Health Recent Developments
Table 99. 23andMe Corporation Information
Table 100. 23andMe Description and Major Businesses
Table 101. 23andMe Product Features and Attributes
Table 102. 23andMe Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. 23andMe Recent Developments
Table 104. bioMérieux Corporation Information
Table 105. bioMérieux Description and Major Businesses
Table 106. bioMérieux Product Features and Attributes
Table 107. bioMérieux Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. bioMérieux Recent Developments
Table 109. EKF Diagnostics Corporation Information
Table 110. EKF Diagnostics Description and Major Businesses
Table 111. EKF Diagnostics Product Features and Attributes
Table 112. EKF Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. EKF Diagnostics Recent Developments
Table 114. Gene by Gene (myDNA) Corporation Information
Table 115. Gene by Gene (myDNA) Description and Major Businesses
Table 116. Gene by Gene (myDNA) Product Features and Attributes
Table 117. Gene by Gene (myDNA) Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. Gene by Gene (myDNA) Recent Developments
Table 119. Fulgent Genetics Corporation Information
Table 120. Fulgent Genetics Description and Major Businesses
Table 121. Fulgent Genetics Product Features and Attributes
Table 122. Fulgent Genetics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. Fulgent Genetics Recent Developments
Table 124. NxGen MDx Corporation Information
Table 125. NxGen MDx Description and Major Businesses
Table 126. NxGen MDx Product Features and Attributes
Table 127. NxGen MDx Revenue (US$ Million) and Gross Margin (2020-2025)
Table 128. NxGen MDx Recent Developments
Table 129. Sonic Genetics Corporation Information
Table 130. Sonic Genetics Description and Major Businesses
Table 131. Sonic Genetics Product Features and Attributes
Table 132. Sonic Genetics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 133. Sonic Genetics Recent Developments
Table 134. My Baby Corporation Information
Table 135. My Baby Description and Major Businesses
Table 136. My Baby Product Features and Attributes
Table 137. My Baby Revenue (US$ Million) and Gross Margin (2020-2025)
Table 138. My Baby Recent Developments
Table 139. AncestryDNA Corporation Information
Table 140. AncestryDNA Description and Major Businesses
Table 141. AncestryDNA Product Features and Attributes
Table 142. AncestryDNA Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. AncestryDNA Recent Developments
Table 144. DiaSorin Corporation Information
Table 145. DiaSorin Description and Major Businesses
Table 146. DiaSorin Product Features and Attributes
Table 147. DiaSorin Revenue (US$ Million) and Gross Margin (2020-2025)
Table 148. DiaSorin Recent Developments
Table 149. Grifols Corporation Information
Table 150. Grifols Description and Major Businesses
Table 151. Grifols Product Features and Attributes
Table 152. Grifols Revenue (US$ Million) and Gross Margin (2020-2025)
Table 153. Grifols Recent Developments
Table 154. BGI Genomics Corporation Information
Table 155. BGI Genomics Description and Major Businesses
Table 156. BGI Genomics Product Features and Attributes
Table 157. BGI Genomics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 158. BGI Genomics Recent Developments
Table 159. Chigene Corporation Information
Table 160. Chigene Description and Major Businesses
Table 161. Chigene Product Features and Attributes
Table 162. Chigene Revenue (US$ Million) and Gross Margin (2020-2025)
Table 163. Chigene Recent Developments
Table 164. Jiajian Medical Testing Corporation Information
Table 165. Jiajian Medical Testing Description and Major Businesses
Table 166. Jiajian Medical Testing Product Features and Attributes
Table 167. Jiajian Medical Testing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 168. Jiajian Medical Testing Recent Developments
Table 169. Genesky Corporation Information
Table 170. Genesky Description and Major Businesses
Table 171. Genesky Product Features and Attributes
Table 172. Genesky Revenue (US$ Million) and Gross Margin (2020-2025)
Table 173. Genesky Recent Developments
Table 174. Berry Genomics Corporation Information
Table 175. Berry Genomics Description and Major Businesses
Table 176. Berry Genomics Product Features and Attributes
Table 177. Berry Genomics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 178. Berry Genomics Recent Developments
Table 179. Weihansi Biomedical Technology Corporation Information
Table 180. Weihansi Biomedical Technology Description and Major Businesses
Table 181. Weihansi Biomedical Technology Product Features and Attributes
Table 182. Weihansi Biomedical Technology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 183. Weihansi Biomedical Technology Recent Developments
Table 184. Annaroad Corporation Information
Table 185. Annaroad Description and Major Businesses
Table 186. Annaroad Product Features and Attributes
Table 187. Annaroad Revenue (US$ Million) and Gross Margin (2020-2025)
Table 188. Annaroad Recent Developments
Table 189. Raw Materials Key Suppliers
Table 190. Distributors List
Table 191. Market Trends and Market Evolution
Table 192. Market Drivers and Opportunities
Table 193. Market Challenges, Risks, and Restraints
Table 194. Research Programs/Design for This Report
Table 195. Key Data Information from Secondary Sources
Table 196. Key Data Information from Primary Sources
List of Figures
Figure 1. Carrier Screening Tests Product Picture
Figure 2. Global Carrier Screening Tests Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. NGS Product Picture
Figure 4. Whole Exome Sequencing Product Picture
Figure 5. Others Product Picture
Figure 6. Global Carrier Screening Tests Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Couple
Figure 8. Individual
Figure 9. Carrier Screening Tests Report Years Considered
Figure 10. Global Carrier Screening Tests Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Carrier Screening Tests Revenue (2020-2031) & (US$ Million)
Figure 12. Global Carrier Screening Tests Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Carrier Screening Tests Revenue Market Share by Region (2020-2031)
Figure 14. Global Carrier Screening Tests Revenue Market Share Ranking (2024)
Figure 15. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 16. NGS Revenue Market Share by Player in 2024
Figure 17. Whole Exome Sequencing Revenue Market Share by Player in 2024
Figure 18. Others Revenue Market Share by Player in 2024
Figure 19. Global Carrier Screening Tests Revenue Market Share by Type (2020-2031)
Figure 20. Global Carrier Screening Tests Revenue Market Share by Application (2020-2031)
Figure 21. North America Carrier Screening Tests Revenue YoY (2020-2031) & (US$ Million)
Figure 22. North America Top 5 Players Carrier Screening Tests Revenue (US$ Million) in 2024
Figure 23. North America Carrier Screening Tests Revenue (US$ Million) by Type (2020 - 2031)
Figure 24. North America Carrier Screening Tests Revenue (US$ Million) by Application (2020-2031)
Figure 25. US Carrier Screening Tests Revenue (2020-2031) & (US$ Million)
Figure 26. Canada Carrier Screening Tests Revenue (2020-2031) & (US$ Million)
Figure 27. Mexico Carrier Screening Tests Revenue (2020-2031) & (US$ Million)
Figure 28. Europe Carrier Screening Tests Revenue YoY (2020-2031) & (US$ Million)
Figure 29. Europe Top 5 Players Carrier Screening Tests Revenue (US$ Million) in 2024
Figure 30. Europe Carrier Screening Tests Revenue (US$ Million) by Type (2020-2031)
Figure 31. Europe Carrier Screening Tests Revenue (US$ Million) by Application (2020-2031)
Figure 32. Germany Carrier Screening Tests Revenue (2020-2031) & (US$ Million)
Figure 33. France Carrier Screening Tests Revenue (2020-2031) & (US$ Million)
Figure 34. U.K. Carrier Screening Tests Revenue (2020-2031) & (US$ Million)
Figure 35. Italy Carrier Screening Tests Revenue (2020-2031) & (US$ Million)
Figure 36. Russia Carrier Screening Tests Revenue (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Carrier Screening Tests Revenue YoY (2020-2031) & (US$ Million)
Figure 38. Asia-Pacific Top 8 Players Carrier Screening Tests Revenue (US$ Million) in 2024
Figure 39. Asia-Pacific Carrier Screening Tests Revenue (US$ Million) by Type (2020-2031)
Figure 40. Asia-Pacific Carrier Screening Tests Revenue (US$ Million) by Application (2020-2031)
Figure 41. Indonesia Carrier Screening Tests Revenue (2020-2031) & (US$ Million)
Figure 42. Japan Carrier Screening Tests Revenue (2020-2031) & (US$ Million)
Figure 43. South Korea Carrier Screening Tests Revenue (2020-2031) & (US$ Million)
Figure 44. Australia Carrier Screening Tests Revenue (2020-2031) & (US$ Million)
Figure 45. India Carrier Screening Tests Revenue (2020-2031) & (US$ Million)
Figure 46. Indonesia Carrier Screening Tests Revenue (2020-2031) & (US$ Million)
Figure 47. Vietnam Carrier Screening Tests Revenue (2020-2031) & (US$ Million)
Figure 48. Malaysia Carrier Screening Tests Revenue (2020-2031) & (US$ Million)
Figure 49. Philippines Carrier Screening Tests Revenue (2020-2031) & (US$ Million)
Figure 50. Singapore Carrier Screening Tests Revenue (2020-2031) & (US$ Million)
Figure 51. Central and South America Carrier Screening Tests Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Central and South America Top 5 Players Carrier Screening Tests Revenue (US$ Million) in 2024
Figure 53. Central and South America Carrier Screening Tests Revenue (US$ Million) by Type (2020-2031)
Figure 54. Central and South America Carrier Screening Tests Revenue (US$ Million) by Application (2020-2031)
Figure 55. Brazil Carrier Screening Tests Revenue (2020-2025) & (US$ Million)
Figure 56. Argentina Carrier Screening Tests Revenue (2020-2025) & (US$ Million)
Figure 57. Middle East and Africa Carrier Screening Tests Revenue YoY (2020-2031) & (US$ Million)
Figure 58. Middle East and Africa Top 5 Players Carrier Screening Tests Revenue (US$ Million) in 2024
Figure 59. South America Carrier Screening Tests Revenue (US$ Million) by Type (2020-2031)
Figure 60. Middle East and Africa Carrier Screening Tests Revenue (US$ Million) by Application (2020-2031)
Figure 61. GCC Countries Carrier Screening Tests Revenue (2020-2025) & (US$ Million)
Figure 62. Israel Carrier Screening Tests Revenue (2020-2025) & (US$ Million)
Figure 63. Egypt Carrier Screening Tests Revenue (2020-2025) & (US$ Million)
Figure 64. South Africa Carrier Screening Tests Revenue (2020-2025) & (US$ Million)
Figure 65. Carrier Screening Tests Industry Chain Mapping
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Carrier Screening Tests market?
The top companies in the global Carrier Screening Tests market are Thermo Fisher Scientific、Eurofins Scientific、Illumina.
Related Reports
Global Carrier Screening Tests Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Carrier Screening Tests market is projected to grow from US$ 2614 million in 2025 to US$ 4814 million by 2032, at a CAGR of 9.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-26
Pages: 180
USD 4900.00
(Single User License)
Global Carrier Screening Tests Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Carrier Screening Tests market size was US$ 2614 million in 2025 and is forecast to reach a readjusted size of US$ 4814 million by 2032 with a CAGR of 9.2% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 126
USD 4250.00
(Single User License)
Carrier Screening Tests - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Carrier Screening Tests was estimated to be worth US$ 2614 million in 2025 and is projected to reach US$ 4814 million, growing at a CAGR of 9.2% from 2026 to 2032.
Published Date: 2026-02-13
Pages: 171
USD 3950.00
(Single User License)
Global Carrier Screening Tests Market Research Report 2026
The global Carrier Screening Tests market was valued at US$ 2614 million in 2025 and is anticipated to reach US$ 4814 million by 2032, at a CAGR of 9.2% from 2026 to 2032.
Published Date: 2026-02-13
Pages: 167
USD 2900.00
(Single User License)
Global Carrier Screening Tests Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Carrier Screening Tests market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 126
USD 4250.00
(Single User License)
Carrier Screening Tests - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Carrier Screening Tests was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-11
Pages: 178
USD 3950.00
(Single User License)
Global Carrier Screening Tests Market Research Report 2025
The global market for Carrier Screening Tests was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-11
Pages: 118
USD 2900.00
(Single User License)
Global and United States Carrier Screening Tests Market Report & Forecast 2024-2030
Carrier screening tests are genetic tests used to determine if an individual carries one or more mutations in their genes that could be passed on to their offspring. These mutations can cause genetic disorders, even if the carrier does not exhibit symptoms themselves.
Published Date: 2024-07-05
Pages: 161
USD 4350.00
(Single User License)
Global Carrier Screening Tests Market Research Report 2024
Carrier screening tests are genetic tests used to determine if an individual carries one or more mutations in their genes that could be passed on to their offspring. These mutations can cause genetic disorders, even if the carrier does not exhibit symptoms themselves.
Published Date: 2024-07-05
Pages: 114
USD 2900.00
(Single User License)
Global Carrier Screening Tests Market Insights, Forecast to 2030
Carrier screening tests are genetic tests used to determine if an individual carries one or more mutations in their genes that could be passed on to their offspring. These mutations can cause genetic disorders, even if the carrier does not exhibit symptoms themselves.
Published Date: 2024-07-05
Pages: 182
USD 4900.00
(Single User License)
Global Carrier Screening Tests Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Carrier Screening Tests market is projected to grow from US$ 2614 million in 2025 to US$ 4814 million by 2032, at a CAGR of 9.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-26
Pages: 180
USD 4900.00 (Single User License)Global Carrier Screening Tests Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Carrier Screening Tests market size was US$ 2614 million in 2025 and is forecast to reach a readjusted size of US$ 4814 million by 2032 with a CAGR of 9.2% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 126
USD 4250.00 (Single User License)Carrier Screening Tests - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Carrier Screening Tests was estimated to be worth US$ 2614 million in 2025 and is projected to reach US$ 4814 million, growing at a CAGR of 9.2% from 2026 to 2032.
Published: 2026-02-13
Pages: 171
USD 3950.00 (Single User License)Global Carrier Screening Tests Market Research Report 2026
The global Carrier Screening Tests market was valued at US$ 2614 million in 2025 and is anticipated to reach US$ 4814 million by 2032, at a CAGR of 9.2% from 2026 to 2032.
Published: 2026-02-13
Pages: 167
USD 2900.00 (Single User License)Global Carrier Screening Tests Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Carrier Screening Tests market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 126
USD 4250.00 (Single User License)Carrier Screening Tests - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Carrier Screening Tests was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-11
Pages: 178
USD 3950.00 (Single User License)Global Carrier Screening Tests Market Research Report 2025
The global market for Carrier Screening Tests was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-11
Pages: 118
USD 2900.00 (Single User License)Global and United States Carrier Screening Tests Market Report & Forecast 2024-2030
Carrier screening tests are genetic tests used to determine if an individual carries one or more mutations in their genes that could be passed on to their offspring. These mutations can cause genetic disorders, even if the carrier does not exhibit symptoms themselves.
Published: 2024-07-05
Pages: 161
USD 4350.00 (Single User License)Global Carrier Screening Tests Market Research Report 2024
Carrier screening tests are genetic tests used to determine if an individual carries one or more mutations in their genes that could be passed on to their offspring. These mutations can cause genetic disorders, even if the carrier does not exhibit symptoms themselves.
Published: 2024-07-05
Pages: 114
USD 2900.00 (Single User License)Global Carrier Screening Tests Market Insights, Forecast to 2030
Carrier screening tests are genetic tests used to determine if an individual carries one or more mutations in their genes that could be passed on to their offspring. These mutations can cause genetic disorders, even if the carrier does not exhibit symptoms themselves.
Published: 2024-07-05
Pages: 182
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now